Universe Pharmaceuticals INC Authorized as The International Branch of National Engineering Technology Research Center
Ji’an, Jiangxi, China, March 22, 2022 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq:…
Month: March 2022
Kane Biotech Successfully Completes Safety and Biocompatibility Studies for DispersinB® Wound Gel in Preparation for Human Clinical Trials
DispersinB® wound gel accelerates wound healing WINNIPEG, Manitoba, March 22, 2022 (GLOBE NEWSWIRE) — Kane…
Cocrystal Pharma to Participate in the Maxim Group 2022 Virtual Growth Conference
BOTHELL, Wash., March 22, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that…
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
DUBLIN, Ireland, March 22, 2022 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company…
Cognition Therapeutics to Report Fourth Quarter and Full Year 2021 Results
Conference Call and Live Audio Webcast Scheduled for Wednesday, March 30, 2022, 8:00 a.m. ET…
National Survey Reveals Insights into Emotional Impact of Psoriasis and Illuminates Need for New Topical Treatments
Arcutis Skin Insights: Uncovering Psoriasis Survey Arcutis Skin Insights: Uncovering Psoriasis Survey Arcutis Skin Insights:…
Entera Bio to Present at 2022 Maxim Virtual Growth Conference
BOSTON and JERUSALEM, March 22, 2022 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a…
Aligos Discontinues Development of its Antisense Oligonucleotide Drug Candidate ALG-020572 in Subjects with Chronic Hepatitis B and Pivots Internal Strategic Emphasis to its Small Molecule Portfolio
Dosing in the first cohort discontinued after multiple reports of ALT flares suggestive of drug-induced…
Iridia Announces Appointment of Thomas H. Cauley, Ph.D. as Vice President, Engineering
Cauley to Lead Development of Company’s Proprietary DNA Data Storage Technology SAN DIEGO, March 22,…
CORRECTION — Statera Biopharma Announces Proposed Underwritten Public Offering
FORT COLLINS, Colo., March 22, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan
LAVAL, Québec, March 22, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
Windtree Announces Results from Its Phase 2 Study of Lucinactant for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) and Lung Injury
Results support the feasibility for development of a potential treatment for critically ill patients with…
Decibel Therapeutics to Participate in Upcoming Investor Conferences
BOSTON, March 22, 2022 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company…
CDR-Life to Present at the American Association for Cancer Research 2022 Annual Meeting
ZÜRICH, Switzerland, March 22, 2022 (GLOBE NEWSWIRE) — CDR-Life Inc., a biotechnology company pioneering a…
Adamis Pharmaceuticals Announces Results of Tempol in Omicron Virus Challenge in Hamster Model
Tempol Reduced Lung Inflammation After High Dose Challenge SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE)…
Voyager Therapeutics Appoints Alfred W. Sandrock, Jr., M.D., Ph.D., as Chief Executive Officer
Renowned neuroscientist brings pioneering drug development expertise and vision to emerging leader in next-generation AAV…
First Wave BioPharma to Participate in Maxim’s 2022 Virtual Growth Conference
BOCA RATON, Fla., March 22, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ: FWBI),…
Matinas BioPharma to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
BEDMINSTER, N.J., March 22, 2022 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage…
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2021 Financial Results
BERKELEY HEIGHTS, N.J., March 22, 2022 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ:…
Zynerba Pharmaceuticals to Participate in the Cantor Rare Orphan Disease Summit
DEVON, Pa., March 22, 2022 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…